Expedited Pharmacometrics Regulatory Submissions Fact Sheet Expedited Pharmacometrics Regulatory Submissions Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…CertaraDecember 8, 2025
AI-Powered PK Reporting: From Days to Minutes On-Demand Webinar AI-Powered PK Reporting: From Days to Minutes AI PK Reports, a component of Phoenix Cloud, turns the protocol, data tables and figures…CertaraDecember 4, 2025
Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings Announcement Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.CertaraDecember 3, 2025
History and Evolution of Innovations in Clinical Pharmacology Publication History and Evolution of Innovations in Clinical Pharmacology This paper reviews how decades of scientific and technological advances have transformed clinical pharmacology and…Danielle PillsburyNovember 26, 2025
Modeling amyloid plaque turnover dynamics improves characterization of drug effects Publication Modeling amyloid plaque turnover dynamics improves characterization of drug effects Researchers modeled how amyloid plaques form and clear in Alzheimer’s disease, helping explain how treatments…CertaraNovember 26, 2025
10 Strategic Foundations for Early Drug Development Guide 10 Strategic Foundations for Early Drug Development Discover effective Early Drug Development strategies to navigate early development with confidence and clarity. Download…CertaraNovember 26, 2025
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges Publication Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges The paper reviews current applications of pediatric PBPK across therapeutic areas and outlines where PBPK…CertaraNovember 21, 2025
Using M&S to Evaluate Oncology Drug Dosing Blog Using M&S to Evaluate Oncology Drug Dosing Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…CertaraNovember 14, 2025
Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix® On-Demand Webinar Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix® Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…CertaraNovember 13, 2025
Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema Publication Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema Certara and Ionis analyzed Phase 3 OASIS-HAE data showing flexible, effective donidalorsen dosing can reduce…CertaraNovember 12, 2025